SE9302203L - Komposition för topisk administration av bispilokarpinsyradiestrar till ögat i form av en vattenlösning - Google Patents
Komposition för topisk administration av bispilokarpinsyradiestrar till ögat i form av en vattenlösningInfo
- Publication number
- SE9302203L SE9302203L SE9302203A SE9302203A SE9302203L SE 9302203 L SE9302203 L SE 9302203L SE 9302203 A SE9302203 A SE 9302203A SE 9302203 A SE9302203 A SE 9302203A SE 9302203 L SE9302203 L SE 9302203L
- Authority
- SE
- Sweden
- Prior art keywords
- eye
- composition
- aqueous solution
- topical administration
- acid diesters
- Prior art date
Links
- 239000002253 acid Substances 0.000 title abstract 2
- 239000007864 aqueous solution Substances 0.000 title abstract 2
- 150000005690 diesters Chemical class 0.000 title abstract 2
- 239000000203 mixture Substances 0.000 title abstract 2
- 238000011200 topical administration Methods 0.000 title abstract 2
- 229920000858 Cyclodextrin Polymers 0.000 abstract 1
- 230000002708 enhancing effect Effects 0.000 abstract 1
- 239000003002 pH adjusting agent Substances 0.000 abstract 1
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/40—Cyclodextrins; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
- A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
- A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nanotechnology (AREA)
- Medical Informatics (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Biophysics (AREA)
- Inorganic Chemistry (AREA)
- Ophthalmology & Optometry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE9302203A SE501482C2 (sv) | 1993-06-24 | 1993-06-24 | Komposition för topisk administration av bispilokarpinsyradiestrar till ögat i form av en vattenlösning |
| PCT/FI1994/000270 WO1995000144A1 (en) | 1993-06-24 | 1994-06-17 | Composition for ophthalmic use |
| AU69731/94A AU6973194A (en) | 1993-06-24 | 1994-06-17 | Composition for ophthalmic use |
| LTIP1970A LT3525B (en) | 1993-06-24 | 1994-06-23 | Composition for ophthalmic use |
| EE9400040A EE9400040A (et) | 1993-06-24 | 1994-08-18 | Oftalmiliseks otstarbeks mõeldud kompositsioon |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE9302203A SE501482C2 (sv) | 1993-06-24 | 1993-06-24 | Komposition för topisk administration av bispilokarpinsyradiestrar till ögat i form av en vattenlösning |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| SE9302203D0 SE9302203D0 (sv) | 1993-06-24 |
| SE9302203L true SE9302203L (sv) | 1994-12-25 |
| SE501482C2 SE501482C2 (sv) | 1995-02-27 |
Family
ID=20390417
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SE9302203A SE501482C2 (sv) | 1993-06-24 | 1993-06-24 | Komposition för topisk administration av bispilokarpinsyradiestrar till ögat i form av en vattenlösning |
Country Status (5)
| Country | Link |
|---|---|
| AU (1) | AU6973194A (sv) |
| EE (1) | EE9400040A (sv) |
| LT (1) | LT3525B (sv) |
| SE (1) | SE501482C2 (sv) |
| WO (1) | WO1995000144A1 (sv) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1996001558A1 (en) * | 1994-07-11 | 1996-01-25 | Pate David W | Anandamide analogue compositions and method of treating intraocular hypertention using same |
| GB9711643D0 (en) * | 1997-06-05 | 1997-07-30 | Janssen Pharmaceutica Nv | Glass thermoplastic systems |
| US6933289B2 (en) | 2003-07-01 | 2005-08-23 | Allergan, Inc. | Inhibition of irritating side effects associated with use of a topical ophthalmic medication |
| US7862552B2 (en) | 2005-05-09 | 2011-01-04 | Boston Scientific Scimed, Inc. | Medical devices for treating urological and uterine conditions |
| EP4247340A4 (en) | 2020-11-18 | 2024-10-02 | Bexson Biomedical, Inc. | COMPLEXING SALT FORMULATIONS OF PHARMACEUTICAL COMPOUNDS |
| US20250345458A1 (en) * | 2022-05-18 | 2025-11-13 | Bexson Biomedical, Inc. | Complexing agent salt formulations of pharmaceutical compounds at low stoichiometric ratios |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS58126810A (ja) * | 1981-12-24 | 1983-07-28 | Kaken Pharmaceut Co Ltd | 抗炎症眼科用液剤およびその製法 |
| TW200402B (sv) * | 1990-08-13 | 1993-02-21 | Senju Pharma Co | |
| FI98815C (sv) * | 1990-11-30 | 1997-08-25 | Santen Oy | Förfarande för framställning av nya farmakologiskt användbara esterderivat av bispilokarpinsyra |
-
1993
- 1993-06-24 SE SE9302203A patent/SE501482C2/sv unknown
-
1994
- 1994-06-17 AU AU69731/94A patent/AU6973194A/en not_active Abandoned
- 1994-06-17 WO PCT/FI1994/000270 patent/WO1995000144A1/en not_active Ceased
- 1994-06-23 LT LTIP1970A patent/LT3525B/lt not_active IP Right Cessation
- 1994-08-18 EE EE9400040A patent/EE9400040A/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| SE501482C2 (sv) | 1995-02-27 |
| LTIP1970A (en) | 1995-01-31 |
| EE9400040A (et) | 1995-12-15 |
| LT3525B (en) | 1995-11-27 |
| SE9302203D0 (sv) | 1993-06-24 |
| WO1995000144A1 (en) | 1995-01-05 |
| AU6973194A (en) | 1995-01-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO971889L (no) | Forbindelser og sammensetninger for levering av aktive midler | |
| ATE210943T1 (de) | Ophthalmologisches abgabesystem | |
| WO2002045662A3 (en) | Anhydrous creams, lotions and gels | |
| MEP10408A (en) | Platinum derivative pharmaceutical formulations | |
| AU532114B2 (en) | Salts of n-substituted-2-pyrrolidone-4-carboxylic acids | |
| SE8305485D0 (sv) | Galenic compositions comprising calcitonin and their use | |
| BR0307893A (pt) | Formulação oftálmica com sistema de goma | |
| DK0695171T3 (da) | Lyosfærer indeholdende gonadotropin | |
| GR1001503B (el) | Μέ?οδος δια την παρασκευή φαρμακευτικών ενώσεων αι οποίαι περιέχουν ως δραστική ουσία καρβονικά οξέα τα οποία περιέχουν ?είον κα?ώς και η χρησιμοποίησις αυτών δια την καταπολέμησιν των ρετροιών. | |
| AU9163701A (en) | Topical composition containing at least one vitamin D or one vitamin D analogue and at least one corticosteroid | |
| NO20030411L (no) | Farmasöytiske sammensetninger for behandlingen av smertefulle, inflammatoriske og ulceröse tilstander av fuktige epiteloverflater slik sommukositt, stomatitt og Behcets syndrom | |
| NO970051L (no) | Vandige risperidon formuleringer | |
| ES2107832T3 (es) | Una composicion farmaceutica para la administracion intranasal de hidroxocobalamina. | |
| DK0562512T3 (da) | Sulfonamidocarbonylpyridin-2-carboxylsyreamider samt deres anvendelse som lægemidler | |
| ATE170194T1 (de) | Neue inklusionskomplexe von salzen von nimesulide mit cyclodextrinen | |
| IT1265101B1 (it) | Derivati dell'acido 2-ammino-4-fenil-4-osso butirrico | |
| EP1354602A4 (en) | MEDICAL COMPOSITIONS WITH DIURETIC AGENT AND IMPROVING INSULIN RESISTANCE | |
| SE9302203D0 (sv) | Composition for ophthalmic use | |
| ATE395064T1 (de) | Kombinationspräparate von 3-n- formylhydroxylaminopropylphosphonsäurederivaten oder 3-n- acetylhydroxylaminopropylphosphonsäurederivaten mit speziellen pharmazeutischen wirkstoffen | |
| WO2002056840A3 (de) | Kosmetisches und/oder pharmazeutisches mittel acylierte aminosaüre enthaltend. | |
| AU7028798A (en) | Use of 2-methylthiazolidine-2,4-dicarboxylic acid as mucolytic agent | |
| DE60003074D1 (de) | Fusidinsäure-derivate | |
| ES2032572T3 (es) | Un procedimiento para la preparacion de una composicion farmaceutica para aplicacion topica sobre la piel. | |
| ES2156877T3 (es) | Anilidas de acidos cicloalquilcarboxilicos. | |
| PT1305033E (pt) | Composicoes farmaceuticas que contem tobramicina e goma de xantano |